ALX Oncology Holdings Inc. (ALXO)

NASDAQ: ALXO · IEX Real-Time Price · USD

6.15

-0.46 (-6.96%)

At close: Jul 19, 2024, 12:00 AM

6.44

+0.29 (4.72%)

Pre-market: Jul 22, 2024, 9:14 AM EDT

ALX Oncology Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Net Income	-166.2	-160.81	-123.48	-83.46	-50.94	-23.27	Upgrade
Depreciation & Amortization	0.84	0.84	0.34	0.05	0.2	0.43	Upgrade
Share-Based Compensation	26.95	26.27	23.84	13.91	5.44	0.3	Upgrade
Other Operating Activities	-2.06	3.33	10.08	1.4	1.81	4.27	Upgrade
Operating Cash Flow	-140.47	-130.36	-89.22	-68.1	-38.29	-14.25	Upgrade
Capital Expenditures	-0.73	-1.27	-1.43	-0.67	-0.03	-0.35	Upgrade
Change in Investments	29.57	45.93	-233.99	0	0	0	Upgrade
Other Investing Activities	-	-	-	-4.26	0.64	-	Upgrade
Investing Cash Flow	28.84	44.66	-235.42	-4.92	0.61	-0.35	Upgrade
Share Issuance / Repurchase	62.94	59.68	0.9	2.75	368.56	0.01	Upgrade
Debt Issued / Paid	-0.46	-0.39	8.96	-0.28	-6.51	5.92	Upgrade
Other Financing Activities	-	-	-	-	100.83	9.43	Upgrade
Financing Cash Flow	62.48	59.29	9.86	2.47	462.88	15.36	Upgrade
Net Cash Flow	-49.15	-26.42	-314.78	-70.55	425.2	0.76	Upgrade
Free Cash Flow	-141.2	-131.64	-90.65	-68.77	-38.32	-14.6	Upgrade
Free Cash Flow Margin	-	-	-	-	-3241.96%	-304.46%	Upgrade
Free Cash Flow Per Share	-2.82	-3.06	-2.23	-1.71	-2.07	-4.75	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).